About NextCure (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Through its Functional, Integrat... Read more
- USD0.48
- USD0.49
- USD0.47
- USD1.82
- 8.50%
- --
- 14.26k
- 141.93k
- 14M
- 0.22
- -65.70%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
